Tag: Arvinas

March 16, 2020

Arvinas Reports Q4 and Full Year 2019 Financial Results

Arvinas reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update.
June 25, 2019

Arvinas Authorized to Proceed with ARV-471

Arvinas (NASDAQ:ARVN) has announced that the US Food and Drug Administration (FDA) has authorized the company’s investigational new drug application...